-
CAMBRIDGE, MA - Mar 11, 2019 - Shimmer, a global leader in wearable technology for research applications, announced that Paolo Bonato, PhD, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, has signed a letter of intent to employ Shimmers Verisense continuous monitoring platform during his next clinical trial to study motor recovery in stroke survivors
Mar 11, 2019
-
LEICESTER, UK - Mar 6, 2019 - A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage of infection
Mar 6, 2019
-
WESTBURY, NY - Mar 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its XPRESSWAY Profile Safety Package, a compendium of 46 gene expression profiles for genes known to play pivotal roles in drug safety assessments
Mar 6, 2019
-
HUNTINGDON VALLEY, PA, UNITED STATES - Mar 5, 2019 - Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samples
Mar 5, 2019
-
PRINCETON, NJ - Mar 5, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the US Centers for Disease Control & Prevention (CDC) has awarded it a contract to strengthen the Agencys death investigation and surveillance systems
Mar 5, 2019
-
GUILDFORD, UNITED KINGDOM - Feb 27, 2019 - MR Solutions latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019
Feb 27, 2019
-
LOS ANGELES, CA, UNITED STATES - Feb 21, 2019 - https://globenewswire.com/news-release/2019/02/21/1739290/0/en/AlloSure-now-available-for-Lung-Transplant-Patients
Feb 21, 2019
-
PRINCETON, NJ - Feb 21, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19
Feb 21, 2019
-
GLASGOW, UK - Feb 12, 2019 - SAW Diagnostics Limited (SAW Dx), an emerging biological sample analysis and point of care diagnostic company, announced today that Innovate UK, the UKs innovation Agency, has awarded the company a £1
Feb 19, 2019
-
CAMBRIDGE, MA, US - Feb 19, 2019 - Shimmer, a global leader in wearable technology for research applications, today announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participants
Feb 19, 2019
-
HERCULES, CA - Feb 14, 2019 - (BUSINESS WIRE) - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rads Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industrys first digital PCR products to receive U
Feb 15, 2019
-
CHICAGO, IL, UNITED STATES - Feb 10, 2019 - Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology that improves clinical laboratory performance, announced the availability of its first fully automated urine particle counter and digital imaging system, the UN-2000
Feb 10, 2019
-
PRINCETON, NJ - Feb 7, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced its latest advances in bringing model-informed precision dosing (MIPD) to the point of care
Feb 7, 2019
-
LONDON, UNITED KINGDOM - Feb 7, 2019 -
Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement
Clinithink,
which
offers healthcare and life sciences organizations powerful clinical data insights through its patented CLiX natural language processing (NLP) platform, has secured a growth-equity investment from TT Capital Partners (TTCP) and the MSD Global Health Innovation Fund (GHI) to expand its global footprint and continue to broaden its service offering
Feb 7, 2019
-
PRINCETON, NJ - Jan 30, 2019 - The WIRB-Copernicus Group®s (WCG) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among members
Jan 30, 2019
-
PRINCETON, NJ - Jan 29, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp® Population-based Simulator
Jan 29, 2019
-
CAMBRIDGE, UK - Jan 18, 2019 - ~~Rapid Biosensor Systems (RBS), the technology company that developed a 2-minute breathalyser test for TB, can adapt its platform technology for screening of lung cancer
Jan 18, 2019
-
PRINCETON, NJ - Jan 15, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services
Jan 15, 2019
-
SAN ANTONIO, TX, UNITED STATES - Jan 8, 2019 - SAN ANTONIO, Jan. 8, 2019 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology
Jan 8, 2019
-
BRISBANE, CA, UNITED STATES - Dec 20, 2018 - BRISBANE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announces the publication of data demonstrating the clinical utility of measuring AlloSure in repeat kidney transplant recipients in the
American Journal of Transplantation
Dec 20, 2018